Vita Life Sciences (ASX:VLS) Total Liabilities: A$26.20 Mil (As of Dec. 2025)

What is Vita Life Sciences Total Liabilities?

Vita Life Sciences ASX:VLS -2.00% 85 Total Liabilities is A$26.20 Mil as of Dec. 2025. GuruFocus rates ASX:VLS with a GF Score™ of 85/100 and a GF Value™ of A$2.48 (Fairly Valued). The stock has 1 warning sign investors should review.

Vita Life Sciences's Total Liabilities for the quarter that ended in Dec. 2025 was A$26.20 Mil.

Vita Life Sciences's quarterly Total Liabilities increased from Dec. 2024 (A$19.61 Mil) to Jun. 2025 (A$22.03 Mil) and increased from Jun. 2025 (A$22.03 Mil) to Dec. 2025 (A$26.20 Mil).

Vita Life Sciences's annual Total Liabilities increased from Dec. 2023 (A$16.48 Mil) to Dec. 2024 (A$19.61 Mil) and increased from Dec. 2024 (A$19.61 Mil) to Dec. 2025 (A$26.20 Mil).

Vita Life Sciences Total Liabilities Related Terms

Vita Life Sciences Total Liabilities Historical Data

* Premium members only.

The historical data trend for Vita Life Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vita Life Sciences Total Liabilities Chart

Vita Life Sciences Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Liabilities

Get a 7-Day Free Trial

14.85

15.30

16.48

19.61

26.20

Vita Life Sciences Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Total Liabilities	Get a 7-Day Free Trial															16.48	19.25	19.61	22.03	26.20

85GF Score

Vita Life Sciences Ltd ASX:VLS

Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Vita Life Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Vita Life Sciences's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	24.165	+	(1.911	+	1.3322676295502E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0.125	+	0)
	=	26.20

Total Liabilities	=	Total Assets (A: Dec. 2025 )	-	Total Equity (A: Dec. 2025 )
	=	82.362	-	56.161
	=	26.20

Vita Life Sciences's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	24.165	+	(1.911	+	1.3322676295502E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0.125	+	0)
	=	26.20

Total Liabilities	=	Total Assets (Q: Dec. 2025 )	-	Total Equity (Q: Dec. 2025 )
	=	82.362	-	56.161
	=	26.20

Frequently Asked Questions Learn more about Total Liabilities →

What does a Total Liabilities of A$26.20 Mil mean?

Vita Life Sciences (ASX:VLS) has a Total Liabilities of A$26.20 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Vita Life Sciences and its competitors.

Is Vita Life Sciences' Total Liabilities too high?

Vita Life Sciences' current Total Liabilities is A$26.20 Mil. Overall, Vita Life Sciences has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Vita Life Sciences' Total Liabilities compare to ZTS?

Vita Life Sciences' Total Liabilities of A$26.20 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Liabilities for a Drug Manufacturers company?

A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Liabilities mean?

A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Vita Life Sciences and its competitors. Vita Life Sciences's current Total Liabilities is A$26.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Vita Life Sciences stock overvalued right now?

Based on GuruFocus' analysis, Vita Life Sciences (ASX:VLS) is currently considered Fairly Valued. The stock's GF Value™ is A$2.48, compared to a current price of A$2.45 — trading 1.2% below its estimated fair value. The current Total Liabilities is A$26.20 Mil. Vita Life Sciences' overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Liabilities calculated?

Total Liabilities is calculated from a company's financial statements. For Vita Life Sciences (ASX:VLS), the current Total Liabilities is A$26.20 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vita Life Sciences (ASX:VLS) Overvalued in 2026?

Based on GuruFocus' analysis, Vita Life Sciences stock appears to be undervalued. The current stock price of A$2.45 is trading 1.2% below its estimated GF Value™ of A$2.48. GuruFocus considers Vita Life Sciences to be Fairly Valued.

Key valuation signals for ASX:VLS:

Total Liabilities: A$26.20 Mil
GF Value™: A$2.48 vs. price of A$2.45 (1.2% below fair value)
GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the ASX:VLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vita Life Sciences Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies ASX:SNT ASX:MVP ASX:LGP ASX:VIT ASX:PKP ASX:IDT ASX:EPN ASX:ECS ASX:PER ASX:CAN XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692

Address 1-5 Chalmers Crescent, Suite 802, Level 8, Mascot, Sydney, NSW, AUS, 2020

Website https://www.vitalifesciences.com

Vita Life Sciences Ltd is an Australian-based pharmaceutical and healthcare company involved in formulating, packaging, selling, and distributing vitamins and supplements. It produces a wide range of premium supplements, vitamins, minerals, herbs, and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, VitaScience, and Herbs of Gold brands throughout the Asia-Pacific region. Vita Life Sciences has two operating segments: VMS Operational, which generates maximum revenue, and VMS Investments. Geographically, the Group generates maximum revenue from Malaysia and Singapore, and the rest from Australia, and China and Vietnam.

85GF Score

Get the complete analysis for ASX:VLS

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.45

Price

A$2.48

GF Value

View ASX:VLS Analysis

See Total Liabilities data for all stocks →